72 Investment Holdings, LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), 72 Investment Holdings, LLC reported 7 stock positions worth $49.1 million. Its top holding was Lenz Therapeutics (LENZ) at 59.8% of the portfolio, followed by Korro Bio (KRRO, 21.5%) and Praxis Precision Medicines I (PRAX, 10.3%). Its holdings were unchanged from Q3 2024.
- Most Recent 13F
- Q2 2026
- Location
- STAMFORD, CT
- CIK
- 0001832749
- Portfolio Value
- $49.1M (Q4 2024)
- SEC Filing
- 0000902664-25-001046 ↗ filed Feb 14, 2025
Holdings Value
Holdings 7 stocks · $49.1M
| LENZ Lenz Therapeutics Inc. | 59.83% | 1,017,751 | $29.4M | No change |
| KRRO Korro Bio Inc. | 21.46% | 276,831 | $10.5M | No change |
| PRAX Praxis Precision Medicines I | 10.33% | 65,933 | $5.1M | No change |
| ANRO Alto Neuroscience Inc. | 5.75% | 667,778 | $2.8M | No change |
| CRBU Caribou Biosciences Inc. | 1.53% | 474,067 | $754K | No change |
| TSBX Turnstone Biologics Corp. | 0.56% | 549,980 | $273K | No change |
| OMGAQ Omega Therapeutics Inc. | 0.54% | 352,941 | $263K | No change |
Portfolio Sells Q3 2024 → Q4 2024
| None this quarter. | |||
Portfolio Buys Q3 2024 → Q4 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $50.0M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q1 2026 | 5 | $49.6M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q4 2025 | 5 | $50.6M | PRAX, LENZ, ANRO, KRRO, CRBU |
| Q3 2025 | 5 | $67.9M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q2 2025 | 6 | $38.3M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q1 2025 | 6 | $35.6M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q4 2024 | 7 | $49.1M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q3 2024 | 7 | $46.5M | LENZ, KRRO, ANRO, PRAX, CRBU |
| Q2 2024 | 7 | $39.8M | LENZ, KRRO, ANRO, PRAX, TSBX |
| Q1 2024 | 7 | $67.1M | KRRO, LENZ, ANRO, PRAX, CRBU |